Rion (6823) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Oct, 2026Executive summary
FY ended Mar. 2025 revenue, operating profit, ordinary profit and net income reached record highs; particle measurement was the main growth driver.
Revenue rose 8.4% to ¥27,877 million and operating profit rose 16.1% to ¥4,033 million.
Ordinary profit increased 15.3% to ¥4,106 million; profit attributable to owners of parent rose 7.8% to ¥2,859 million.
Comprehensive income declined 6.3% to ¥2,938 million.
Financial highlights
Gross profit was ¥14,062 million, up from ¥13,046 million; gross margin was 50.4%, versus 50.7% a year earlier.
Operating margin rose to 14.5% from 13.5%; basic EPS was ¥232.19, up from ¥215.51.
Total assets were ¥39,132 million, net assets ¥31,435 million, and the capital adequacy ratio 80.3%.
Cash and cash equivalents at year-end were ¥5,848 million, up from ¥4,860 million.
Outlook and guidance
FY Mar. 2026 guidance: revenue ¥28,900 million, operating and ordinary profit ¥4,400 million, net income ¥3,150 million, and EPS ¥255.70.
FY Mar. 2027 and FY Mar. 2028 revenue targets are ¥29,800 million and ¥30,700 million; operating profit targets are ¥4,600 million and ¥4,850 million.
FY Mar. 2031 targets: revenue of at least ¥35 billion, operating margin of at least 15%, and ROE of at least 10%.
All segments are expected to grow revenue and profit through new products and market opportunities; particle-measurement growth is expected to moderate after backlog normalization.
Latest events from Rion
- Record H1 sales and profits, with semiconductor demand driving particle-measurement growth.6823
Q2 2024 - Record FY2024 results were led by particle measurement, with growth forecast through FY2027.6823
Q4 2024 - First-quarter sales and profits rose year-over-year, with strong margins and positive full-year outlook.6823
Q1 2027 - Record FY26 results underpin growth plans, while investment pressures selected segment profits.6823
Q4 2026 - Q1 FY2025 sales rose 5.7% but profits fell sharply; full-year outlook remains cautiously positive.6823
Q1 2025 - Record H1 results led by particle instruments support FY3/25 growth guidance.6823
Q2 2025 - Solid nine-month growth and higher dividend forecast, with continued profit gains expected.6823
Q3 2025 - Record first-half results support FY26 guidance of ¥28.9bn sales and ¥4.4bn operating profit.6823
Q2 2026 - Strong profit growth and higher margins reported for Q1 FY2025, with positive full-year outlook.6823
Q1 2026